Price $227.34 |
Market Cap
17.42B
|
Sector Health Care |
Div. Growth
100.00%
|
|
P/E
29.6
|
P/B
2.31
|
P/S
1.34
|
Dividend %
1.40%
|
|
P/CF
65.0
|
P/FCF
25.2
|
Op. Cash Flow
1.4M
|
FCF
8.3
|
|
Op. Margin
7.00%
|
Net Margin
4.90%
|
ROE
7.10%
|
ROI
9.50%
|
|
ROA
3.50%
|
EPS Growth
-60.20%
|
Current Ratio
1.5
|
Debt/Equity
50.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
| Evogene Ltd (EVGN) | $3.06 | - | - | 22.7M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
